Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma (Q33412728)

26 July 2017

title

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma (English)

1 reference

metastatic renal cell carcinoma

26 July 2017

1 reference

1 reference

13

R J Motzer

1 reference

26 July 2017

T E Hutson

1

1 reference

26 July 2017

R M Bukowski

2

1 reference

26 July 2017

B I Rini

3

1 reference

26 July 2017

M E Gore

4

1 reference

26 July 2017

J M Larkin

5

1 reference

26 July 2017

R A Figlin

6

1 reference

26 July 2017

C H Barrios

7

1 reference

26 July 2017

B Escudier

8

1 reference

26 July 2017

X Lin

9

1 reference

26 July 2017

K Fly

10

1 reference

26 July 2017

B Martell

11

1 reference

26 July 2017

E Matczak

12

1 reference

26 July 2017

language of work or name

English

0 references

publication date

16 January 2014

1 reference

British Journal of Cancer

26 July 2017

published in

1 reference

26 July 2017

volume

110

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

1125-1132

1 reference

Disability, health, and multiple chronic conditions among people eligible for both Medicare and Medicaid, 2005-2010

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

A gap in disease-specific survival between younger and older adults with de novo metastatic renal cell carcinoma: results of a SEER database analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Systemic therapies for metastatic renal cell carcinoma in older adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Factors influencing general practitioners in the referral of elderly cancer patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

EAU guidelines on renal cell carcinoma: the 2010 update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Renal cell carcinoma in young and old patients--is there a difference?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Vacuum-assisted closure therapy in ureteroileal anastomotic leakage after surgical therapy of bladder cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Interaction between comorbidity and cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

The effects of aging on tumor growth and angiogenesis are tumor-cell dependent

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Sunitinib in patients with metastatic renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Effect of host age on tumor growth rate in rodents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Never too old? Age should not be a barrier to enrollment in cancer clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

The presentation, treatment and outcome of renal cell carcinoma in old age.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950861

Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.

21 June 2018

1 reference

https://api.crossref.org/works/10.1038/BJC.2013.832

Undertreatment strongly decreases prognosis of breast cancer in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BJC.2013.832

Impact of referral patterns on the use of chemotherapy for lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BJC.2013.832

Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BJC.2013.832

Participation of patients 65 years of age or older in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BJC.2013.832

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BJC.2013.832

The cancer survival gap between elderly and middle-aged patients in Europe is widening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BJC.2013.832

Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BJC.2013.832

Participation of elderly patients in registration trials for oncology drug applications in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BJC.2013.832

The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002

21 January 2018

1 reference

12 December 2020

Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma

1 reference

12 December 2020

Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study

1 reference

12 December 2020

Poorer survival of elderly patients with ovarian cancer: a population-based study

1 reference

12 December 2020

Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?

1 reference

12 December 2020

Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration

1 reference

12 December 2020

Association between age and the utilization of radiotherapy in Ontario

1 reference

12 December 2020

Altered angiogenesis underlying age-dependent changes in tumor growth

1 reference

12 December 2020

Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma

1 reference

12 December 2020

A population-based study of the extent of surgical resection of potentially curable colon cancer

1 reference

12 December 2020

Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?

1 reference

12 December 2020

Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2013.832

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference